Cutler Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Hold
0
1388
2022
Q4
Hold
0
1693
2022
Q3
Sell
-800
Closed -$11K 1868
2022
Q2
$11K Sell
800
-4,646
-85% -$63.9K ﹤0.01% 1339
2022
Q1
$131K Sell
5,446
-29,459
-84% -$709K 0.01% 729
2021
Q4
$814K Buy
34,905
+27,405
+365% +$639K 0.03% 311
2021
Q3
$124K Buy
7,500
+7,400
+7,400% +$122K 0.01% 873
2021
Q2
$2K Hold
100
﹤0.01% 1944
2021
Q1
$2K Buy
+100
New +$2K ﹤0.01% 1864
2020
Q4
Hold
0
1734
2020
Q3
Hold
0
1649
2020
Q2
Hold
0
1495
2020
Q1
Sell
-4,100
Closed -$175K 1380
2019
Q4
$175K Buy
4,100
+827
+25% +$35.3K 0.01% 552
2019
Q3
$117K Buy
+3,273
New +$117K 0.01% 580
2019
Q2
Sell
-6,878
Closed -$184K 1516
2019
Q1
$184K Buy
6,878
+4,011
+140% +$107K 0.02% 466
2018
Q4
$46K Buy
+2,867
New +$46K ﹤0.01% 851
2018
Q3
Sell
-2,541
Closed -$38K 1567
2018
Q2
$38K Sell
2,541
-30,195
-92% -$452K ﹤0.01% 965
2018
Q1
$735K Buy
32,736
+18,365
+128% +$412K 0.06% 224
2017
Q4
$432K Sell
14,371
-2,773
-16% -$83.4K 0.02% 420
2017
Q3
$645K Sell
17,144
-12,290
-42% -$462K 0.02% 360
2017
Q2
$820K Sell
29,434
-17,739
-38% -$494K 0.03% 349
2017
Q1
$1.62M Buy
47,173
+35,976
+321% +$1.24M 0.07% 196
2016
Q4
$322K Sell
11,197
-13,653
-55% -$393K 0.01% 646
2016
Q3
$790K Buy
24,850
+8,908
+56% +$283K 0.04% 283
2016
Q2
$517K Buy
15,942
+11,933
+298% +$387K 0.03% 371
2016
Q1
$112K Sell
4,009
-40,379
-91% -$1.13M 0.01% 877
2015
Q4
$1.58M Buy
+44,388
New +$1.58M 0.09% 142